🔎 Trials Near Me

Gara Jalqabaatti › Kanisa Harkaa › Michigan › Detroit

Qorannoo klinikaalii Kanisa Harkaa Detroit, MI keessatti

Qorannoo 16 Kanisa Harkaa f Detroit fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

The Vanguard Study: Testing a New Way to Screen for Cancer

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
  • Henry Ford Hospital, Detroit
  • Henry Ford Medical Center - Detroit Northwest, Detroit
Umuriin 45 hanga 75 · Saalaa hunda · Haaromfame 06-Onk-2026 · NCT06995898

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
  • Henry Ford Health Saint John Hospital, Detroit
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07283939

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Henry Ford Hospital, Detroit
  • Henry Ford Health Saint John Hospital, Detroit
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Namoota walitti qabaa jiraSadarkaa 1
  • Barbara Ann Karmanos Cancer Institute, Detroit
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Barbara Ann Karmanos Cancer Institute, Detroit
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07213791

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Karmanos Cancer Institiute, Detroit
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT06293898

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Namoota walitti qabaa jiraSadarkaa 1
  • Henry Ford Cancer Institute, Detroit
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06253871

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Karmanos Cancer Institute, Detroit
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Hag-2026 · NCT05592626

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Henry Ford Cancer Institute, Detroit
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ado-2026 · NCT04198766

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Investigative Site #120, Detroit
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ado-2026 · NCT06974110

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Karmanos Cancer Institute, Detroit
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT05208762

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Henry Ford Health System, Detroit
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ado-2026 · NCT06657144

Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy

Namoota walitti qabaa jiraSadarkaa 1
  • Henry Ford Cancer-Detroit, Detroit
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Mud-2025 · NCT06065371

A Beta-only IL-2 ImmunoTherapY Study

Namoota walitti qabaa jiraSadarkaa 1/2
  • Karmanos Cancer Institute, Detroit
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ado-2025 · NCT05086692

Qorannoo Kanisa Harkaa magaalota biroo keessatti

Qorannoo biroo Detroit keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 07-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.